Gabriel Helmlinger
6PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 11, 2025
A Systematic Comparative Analysis of Tumor Size Models Based on Erlotinib Clinical Data in Advanced NSCLC.Anna Mishina, Kirill Zhudenkov, Gabriel Helmlinger
|Jan 25, 2021
Longitudinal FEV1 and Exacerbation Risk in COPD: Quantifying the Association Using Joint Modelling.Kirill Zhudenkov, Robert Palmér, Alexandra Jauhiainen
|Sep 16, 2020
Dose dependence of treatment-related adverse events for immune checkpoint inhibitor therapies: a model-based meta-analysis.Boris Shulgin, Yuri Kosinsky, Andrey Omelchenko
|Aug 20, 2019
Comparison of the urinary glucose excretion contributions of SGLT2 and SGLT1: A quantitative systems pharmacology analysis in healthy individuals and patients with type 2 diabetes treated with SGLT2 inhibitors.Tatiana Yakovleva, Victor Sokolov, Lulu Chu
|Mar 01, 2018
Radiation and PD-(L)1 treatment combinations: immune response and dose optimization via a predictive systems model.Yuri Kosinsky, Simon J Dovedi, Kirill Peskov
Pageof 1
Frequent Collaborators
4 joint publications
Kirill Peskov
2 joint publications
Victor Sokolov
1 joint publications
Tatiana Yakovleva
1 joint publications
Weifeng Tang
1 joint publications
David W Boulton
1 joint publications
Robert C Penland
1 joint publications
Ulrika Wählby Hamrén
1 joint publications
Anna Mishina
1 joint publications
Kirill Zhudenkov
1 joint publications
Anna Mikhailova